The positive expression rate of the HER-2/neu protein in endometrial carcinoma is associated with clinical staging, a lower degree of tissue differentiation, and lymph node metastasis [7]. Here, ERBB2 is linked to metastatic malignant neoplasm in the lymph nodes.